About Gomel Regional Clinical Oncology Dispensary
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Clinical Trials at Gomel Regional Clinical Oncology Dispensary
During the past decade, Gomel Regional Clinical Oncology Dispensary conducted 9 clinical trials. In the 10-year time frame, 9 clinical trials started and 4 clinical trials were completed, i.e. on
average, 44.4% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 1 clinical trials were completed. i.e. 100%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Study Evaluating Neratinib Plus Paclitaxel VS Trastuzumab Plus Paclitaxel In ErbB-2 Positive Advanced Breast Cancer
2009-08-21
2018-06-28
Completed
479
Study of AXL1717 Compared to Docetaxel to Treat Squamous Cell Carcinoma or Adenocarcinoma of the Lung
2011-12-01
2013-12-01
Completed
100
A Safety and Efficacy Study of BCD-021 With Paclitaxel and Carboplatin Compared to Avastin With Paclitaxel and Carboplatin in Non-Small Cell Lung Cancer
2012-10-01
2014-11-01
Completed
138
A Safety and Efficacy Study of BCD-022 With Paclitaxel Compared to Herceptin With Paclitaxel in HER2+ Metastatic Breast Cancer Patients
2012-10-01
2017-12-01
Completed
225
Dose Finding Study in Colorectal Cancer Patients Receiving 5-FU-based Chemotherapy to Assess the Efficacy of Elsiglutide in the Prevention of Chemotherapy Induced Diarrhea (CID)
2015-02-01
2016-02-01
Completed
498
Study of TAS-102 or Placebo Plus BSC in Patients With Metastatic Gastric Cancer
2016-02-24
2019-12-19
Completed
507
Efficacy, Safety and Pharmacokinetics of BCD-100 (Anti-PD-1) Monotherapy as Second Line Treatment in Patients With Non-Small Cell Lung Cancer (DOMINUS)
2017-09-19
2021-08-10
Unknown status
218
A Study Comparing Obinutuzumab and BGB-3111 Versus Obinutuzumab Alone in Treating R/R Follicular Lymphoma
2017-11-15
2023-11-01
Active, not recruiting
217
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "Gomel Regional Clinical Oncology Dispensary" #1 sponsor was "Biocad" with 4 trials, followed by "Janssen Research & Development, LLC" with 3 trials
sponsored, "Axelar AB" with 1 trials sponsored, "BeiGene" with 1 trials sponsored and "EirGenix, Inc."
with 1 trials sponsored. Other sponsors include -2 different institutions and
companies that sponsored additional 8 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Gomel Regional Clinical Oncology Dispensary"
#1 collaborator was "Chiltern International Inc." with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were
collaborators in the rest 1 trials.
Clinical Trials Conditions at Gomel Regional Clinical Oncology Dispensary
According to Clinical.Site data, the most researched conditions in "Gomel Regional Clinical Oncology Dispensary" are
"Breast Cancer" (2 trials), "Adenocarcinoma of the Lung" (1 trials), "Drug and/or Toxin-induced Diarrhea" (1 trials), "Human Epithelial Receptor (HER)-2 Positive Breast Cancer" (1 trials) and "Melanoma" (1 trials). Many other conditions were trialed in "Gomel Regional Clinical Oncology Dispensary" in a lesser frequency.
Clinical Trials Intervention Types at Gomel Regional Clinical Oncology Dispensary
Most popular intervention types in "Gomel Regional Clinical Oncology Dispensary" are "Drug" (11 trials), "Other" (2 trials) and "Biological" (1 trials). Other intervention types were less common.
The name of intervention was led by "Paclitaxel" (3 trials), "Placebo" (3 trials), "BCD-100" (2 trials), "Carboplatin" (2 trials) and "Docetaxel" (2 trials). Other intervention names were less common.
Clinical Trials Genders at Gomel Regional Clinical Oncology Dispensary
The vast majority of trials in "Gomel Regional Clinical Oncology Dispensary" are
8 trials for "All" genders, 3 trials for "Female" genders and 2 trials for "Male" genders.
Clinical Trials Status at Gomel Regional Clinical Oncology Dispensary
Currently, there are NaN active trials in "Gomel Regional Clinical Oncology Dispensary".
undefined are not yet recruiting,
1 are recruiting,
3 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 8 completed trials in Gomel Regional Clinical Oncology Dispensary,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Gomel Regional Clinical Oncology Dispensary, 1 "Phase 1"
clinical trials were conducted, 7 "Phase 2" clinical
trials and 6 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".